BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 9695205)

  • 1. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].
    Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
    Strahlenther Onkol; 1998 Mar; 174(3):149-55. PubMed ID: 9524624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.
    Rahn R; Adamietz IA; Boettcher HD; Schaefer V; Reimer K; Fleischer W
    Dermatology; 1997; 195 Suppl 2():57-61. PubMed ID: 9403257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
    Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
    Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer.
    Rashad UM; Al-Gezawy SM; El-Gezawy E; Azzaz AN
    J Laryngol Otol; 2009 Feb; 123(2):223-8. PubMed ID: 18485252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2003 Dec; 25(12):1057-70. PubMed ID: 14648865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoglobulin for prevention of radiogenic mucositis].
    Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
    HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of standardized oral hygiene in the prevention and therapy of mucositis in patients treated with radiochemotherapy of head and neck neoplasms].
    Hasenau C; Clasen BP; Roettger D
    Laryngol Rhinol Otol (Stuttg); 1988 Nov; 67(11):576-9. PubMed ID: 3236992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can prophylactic application of immunoglobulin decrease radiotherapy-induced oral mucositis?
    Mose S; Adamietz IA; Saran F; Thilmann C; Heyd R; Knecht R; Böttcher HD
    Am J Clin Oncol; 1997 Aug; 20(4):407-11. PubMed ID: 9256900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
    Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
    J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of Oral Mucositis with Iodine Solution during Concurrent Chemoradiation of Head and Neck Cancer: Preliminary Results of a Double-Blind, Randomized Controlled Trial.
    Namuangchan Y; Chailertwanich O; Susinsamphan S; Supakalin N; Supaadirek C; Krusun S; Pesee M; Thamronganantasakul K
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2445-2454. PubMed ID: 37505779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
    Dietz A; Nollert J; Maier H; Rudat V; Flentje M
    HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
    Watanabe T; Ishihara M; Matsuura K; Mizuta K; Itoh Y
    Int J Cancer; 2010 Oct; 127(8):1984-90. PubMed ID: 20104529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.
    Vokurka S; Bystrická E; Koza V; Scudlová J; Pavlicová V; Valentová D; Bocková J; Misaniová L
    Support Care Cancer; 2005 Jul; 13(7):554-8. PubMed ID: 15798915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.